Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,690 | 17,981 | 24,145 | 34,110 | 19,913 |
| Receivables | 7,512 | 5,866 | 13,005 | 16,918 | 34,238 |
| Inventories | 8,710 | 9,899 | 7,776 | 10,976 | 22,139 |
| Other current assets | 4,561 | 1,987 | 975 | 1,343 | 2,740 |
| TOTAL | $33,082 | $36,633 | $47,345 | $65,547 | $81,521 |
| Non-Current Assets | |||||
| PPE Net | 19,159 | 25,272 | 18,111 | 25,894 | 34,144 |
| Investments And Advances | N/A | N/A | N/A | 0 | 191 |
| Intangibles | 854 | 1,032 | 39 | 44 | 228 |
| Other Non-Current Assets | 635 | 1,000 | 0 | 876 | 2,147 |
| TOTAL | $20,648 | $27,304 | $18,150 | $26,814 | $36,710 |
| Total Assets | $53,730 | $63,937 | $65,495 | $92,361 | $118,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 258 | 2,105 | 523 | N/A | 7,375 |
| Accounts payable and accrued liabilities | 4,237 | 2,130 | 3,539 | 2,991 | 5,549 |
| Accrued Expenses | 1,688 | 3,018 | 1,937 | 1,597 | 7,792 |
| Other current liabilities | N/A | 829 | N/A | N/A | N/A |
| TOTAL | $10,495 | $10,863 | $9,456 | $8,877 | $24,245 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 10,542 |
| Deferred Revenues | 607 | 391 | 1,321 | 1,321 | 1,003 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2 | 4,811 |
| TOTAL | $51 | $69 | $34 | $338 | $15,572 |
| Total Liabilities | $10,546 | $10,932 | $9,490 | $9,215 | $39,817 |
| Shareholders' Equity | |||||
| Common Shares | 201,210 | 200,244 | 191,256 | 190,550 | 138,508 |
| Retained earnings | -187,426 | -176,732 | -163,649 | -129,343 | -74,542 |
| Other shareholders' equity | 29,400 | 29,493 | 28,398 | 21,939 | 14,448 |
| TOTAL | $43,184 | $53,005 | $56,005 | $83,146 | $78,414 |
| Total Liabilities And Equity | $53,730 | $63,937 | $65,495 | $92,361 | $118,231 |